Sandra J. Meech

Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis

Marilyn Johnson, Rachelle Nuss, Nigel S. Key et al. · The Journal of Pediatrics · 1996 · 180 citations

Autoimmune Disease, Postvaricella Purpura Fulminans, Lupus +9

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Vera Hirsh, Luis Paz‐Ares, Michael Boyer et al. · Journal of Clinical Oncology · 2011 · 137 citations · Full text

Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer

Rachel Humphrey, Laura Brockway-Lunardi, Damian Bonk et al. · JNCI Journal of the National Cancer Institute · 2011 · 133 citations · Full text

Engineering, Cancer Management, Tumor Biology +18

Adenoviral-mediated gene transfer in lymphocytes

Ronald P. Leon, Tammy E. Hedlund, Sandra J. Meech et al. · Proceedings of the National Academy of Sciences · 1998 · 127 citations · Full text

Signal Transduction, Molecular Physiology, Viral Fiber Protein +15

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

C. Manegold, Nico van Zandwijk, A. Szczęsna et al. · Annals of Oncology · 2011 · 126 citations · Full text

Oncology, Tlr9 Agonist, Medicine +8